STOCK GOODIES PLAYS OF THE WEEK

[PennyStock Alert]

ARYC: Arrayit.Com

Market Cap is only $1million, yet it has great revenue of over $3 million last year !! Trading at a tiny fraction of what it should be.

Located in Silicon Valley

O/S only 509,702,159

Volume is steadily increasing :)

Extremely undervalued at .0021

Biotech Microarray Products are selling $$$$$!

Please do DD, this is the one!!!!

Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.Arrayit Corp. (OTCQB: ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

The company recently announced an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth. Read the details of this development in the following report: http://bit.ly/_ARYC-AnalystReport

This weeks news:

Arrayit reports $47,500 microarray sale to life science leader Bio-Medical Science BMS Korea

Arrayit clinical microarray correctly identifies E. coli pathogen in blinded FDA validation http://www.fda.gov

Arrayit Corporation ?@arrayit
Arrayit receives positive feedback from US Food and Drug Administration FDA Silver Spring MD http://www.fda.gov/Food
Arrayit Corporation ?@arrayit
Arrayit reports $179,430 NanoPrint™ 2 Microarray Printer RFQ Canadian Food Inspection Agency http://www.inspection.gc.ca/eng/1297964599443/1297965645317 … pic.twitter.com/9EqOdzk7Rw

Arrayit Corporation ?@arrayit
Arrayit reports microarray printing pin sale to EU distributor Proteigene St. Marcel France http://proteigene.com

Arrayit delivers enhanced Food Safety Platform to United States Department Agriculture USDA http://www.usda.gov/wps/portal/u

Arrayit patented ChipMaker® microarray technology empowers FDA scientists to develop an HIV test for public health http://arrayit.com/Hsia2007.pdf

Arrayit completes 110k note conversion on 10/7/15 with $0.00 principal remaining from institutional investor Macallan Partners New York.